Skip to main content
Clinical Trials/NL-OMON30860
NL-OMON30860
Not yet recruiting
Phase 3

Assessment of Perinatal Outcome after Sustained Tocolysis in Early Labour (APOSTEL II) - APOSTEL II

Academisch Medisch Centrum0 sites400 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
threatened preterm labour
Sponsor
Academisch Medisch Centrum
Enrollment
400
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women with a gestational age between 24\+0 and 31\+6 weeks who are spontaneously in labour, and who have been treated for 48 hours with tocolytics.

Exclusion Criteria

  • Women with signs of intra\-uterine infection, women whose child has signs of fetal distress (abnormal CTG or biophysical profile) or major congenital malformation and women with any contraindication for the use of nifedipine or having a maternal disease (severe hypertension, HELLP syndrome, preeclampsia or other) or other reason for delivery.

Outcomes

Primary Outcomes

Not specified

Similar Trials